4.7 Article

Multi-target spectral moment: QSAR for antifungal drugs vs. different fungi species

期刊

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 44, 期 10, 页码 4051-4056

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2009.04.040

关键词

Multi-target QSAR; Markov model; Antifungal drugs; spectral moments; Linear discriminant analysis

资金

  1. Programme Isidro Parga Pondal [IN89A 2008/117-0]
  2. Xunta de Galicia
  3. European Social Fund (ESF)

向作者/读者索取更多资源

The most important limitation of antifungal QSAR models is that they predict the biological activity of drugs against only one fungal species. This is determined due the fact that most of the up-to-date reported molecular descriptors encode only information about the molecular structure. Consequently, predicting the probability with which a drug is active against different fungal species with a single unifying model is a goal of major importance. Herein, we use the Markov Chain theory to calculate new multi-target spectral moments to fit a QSAR model that predicts the antifungal activity of more than 280 drugs against 90 fungi species. Linear discriminant analysis (LDA) was used to classify drugs into two classes as active or non-active against the different tested fungal species whose data we processed. The model correctly classifies 12434 out of 12566 non-active compounds (98.95%) and 421 out of 468 active compounds (89.96%). Overall training predictability was 98.63%. Validation of the model was carried out by means of external predicting series, the model classifying, thus, 6216 out of 6277 non-active compounds and 215 out of 239 active compounds. Overall training predictability was 98.7%. The present is the first attempt to calculate, within a unifying framework, the probabilities of antifungal action of drugs against many different species based on spectral moment's analysis. (C) 2009 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据